Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
J Med Chem ; 61(24): 11074-11100, 2018 12 27.
Article in English | MEDLINE | ID: mdl-30384606

ABSTRACT

A HTS campaign identified compound 1, an excellent hit-like molecule to initiate medicinal chemistry efforts to optimize a dual ROCK1 and ROCK2 inhibitor. Substitution (2-Cl, 2-NH2, 2-F, 3-F) of the pyridine hinge binding motif or replacement with pyrimidine afforded compounds with a clean CYP inhibition profile. Cocrystal structures of an early lead compound were obtained in PKA, ROCK1, and ROCK2. This provided critical structural information for medicinal chemistry to drive compound design. The structural data indicated the preferred configuration at the central benzylic carbon would be ( R), and application of this information to compound design resulted in compound 16. This compound was shown to be a potent and selective dual ROCK inhibitor in both enzyme and cell assays and efficacious in the retinal nerve fiber layer model after oral dosing. This tool compound has been made available through the AbbVie Compound Toolbox. Finally, the cocrystal structures also identified that aspartic acid residues 176 and 218 in ROCK2, which are glutamic acids in PKA, could be targeted as residues to drive both potency and kinome selectivity. Introduction of a piperidin-3-ylmethanamine group to the compound series resulted in compound 58, a potent and selective dual ROCK inhibitor with excellent predicted drug-like properties.


Subject(s)
Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , rho-Associated Kinases/antagonists & inhibitors , Administration, Oral , Animals , Biological Availability , Crystallography, X-Ray , Cytochrome P-450 CYP2C9 Inhibitors/chemistry , Cytochrome P-450 CYP2C9 Inhibitors/pharmacology , Cytochrome P-450 CYP3A Inhibitors/chemistry , Cytochrome P-450 CYP3A Inhibitors/pharmacology , Drug Design , Drug Evaluation, Preclinical/methods , Half-Life , Humans , Mice, Inbred C57BL , Optic Nerve Injuries/drug therapy , Optic Nerve Injuries/pathology , Rats, Sprague-Dawley , Structure-Activity Relationship , rho-Associated Kinases/chemistry
2.
Langmuir ; 24(6): 2465-71, 2008 Mar 18.
Article in English | MEDLINE | ID: mdl-18269295

ABSTRACT

The chain conformation and dynamics of hydrocarbon and perfluorocarbon fatty acids adsorbed on 4 nm ZrO2 particles were characterized by solid-state 13C chemical shift and 19F NMR relaxation measurements, respectively, and compared to those from previous studies on lower surface area fumed metal oxide powders. The interdigitation of chains between neighboring particles, which increases with chain length, can be detected from the splitting of the 13C NMR and 19F NMR signals of the CH3 and CF3 groups, respectively. Similar to the case of alkanethiol self-assembled monolayers (SAMs) on gold nanoparticles, this interdigitation allows for efficient chain packing despite the high surface curvature. The hydrocarbon chains on the ZrO2 nanoparticles are more ordered, and the reversible chain length dependent order-disorder transition temperatures are elevated relative to those of the same fatty acids adsorbed on fumed ZrO2 powder. Likewise, the 19F spin lattice relaxation times of the fluorocarbon chains approach those of the bulk acids with increasing chain length and interdigitation, indicating densely packed chains.


Subject(s)
Fatty Acids/chemistry , Fluorocarbons/chemistry , Hydrocarbons/chemistry , Nanoparticles/chemistry , Zirconium/chemistry , Adsorption , Magnetic Resonance Spectroscopy/methods , Magnetic Resonance Spectroscopy/standards , Particle Size , Reference Standards , Spectroscopy, Fourier Transform Infrared/methods , Surface Properties , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL